Last edition
News about Market
Indian Pharma Exporters Face Delayed Payments from Cairo-Based API importer, Embassy Cautions
The Embassy of India in Cairo has advised Indian pharmaceutical exporters to exercise caution when dealing with an Egyptian company, citing significant delays in payment settlements.
Market | 13/09/2025 | By Dineshwori | 406
Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
Avidity Biosciences will use the funds, along with existing reserves, to advance late-stage clinical programmes, prepare for potential launches, expand commercial infrastructure, progress its AOC platform, and for general corporate needs.
Market | 13/09/2025 | By Dineshwori | 468
LB Pharmaceuticals Raises 285 Million USD in Biotech IPO, Valued at Over 300 Million
LB Pharmaceuticals has raised 285 million USD in its initial public offering in the United States, the biotechnology company has confirmed, marking the first major biotech IPO since February. The New York-based firm sold 19 million shares at 15 USD apiece, pricing the offering within its earlier indicated range of 14 to 16 USD per share.
Market | 12/09/2025 | By Darshana | 226
Pfizer, Novartis, Roche Lead Net-Zero Pharma Supply Chain Transition
Europe currently dominates the global net-zero pharma supply chain market supported by strict climate regulations, while Asia-Pacific is the fastest-growing region, spurred by new government-led sustainability policies.
Market | 11/09/2025 | By Dineshwori | 1319
GTCR to Acquire Zentiva in 4.8 Billion USD Private Equity Buy-out
Private equity firm GTCR has entered into an agreement to acquire Zentiva, a pharmaceutical company headquartered in Europe, for approximately 4.8 billion USD (roughly 4.4 billion EURO based on current exchange rates).
Market | 11/09/2025 | By Darshana | 217
LB Pharmaceuticals Seeks 322 Million USD Valuation in Rare Biotech IPO Amid Market Slowdown
LB Pharmaceuticals, a cash-strapped drug developer, is targeting a valuation of up to 322 million USD (approximately 295 million EURO) in its upcoming New York initial public offering, which could become the first significant biotech listing in several months.
Market | 09/09/2025 | By Darshana | 332
Johnson & Johnson has launched two new products for astigmatic patients in Europe and the Middle East, including the first daily disposable multifocal contact lens for astigmatic presbyopes.
Market | 04/09/2025 | By Dineshwori | 773
Asia-Pacific Emerges as Fastest-Growing Market for Surgical Robotics
The Asia Pacific region is gaining momentum in the global surgical robotics market, with countries like China, India, Japan, and South Korea driving forward the regional surge in demand and deployment.
Market | 03/09/2025 | By Dineshwori | 415
Evernorth Invests USD 3.5 Billion in Shields to Deepen Specialty Pharmacy Reach
Evernorth, a subsidiary of Cigna Group, is investing USD 3.5 billion in Shields Health Solutions, a company focused on specialty pharmacy management. This investment arrives as Shields establishes itself as a standalone entity following its acquisition by private equity firm Sycamore Partners after the Walgreens demerger.
Market | 03/09/2025 | By Darshana | 356
CapVest Acquires Majority Stake in Stada, Abandoning IPO Plans
CapVest Partners, a London-based private equity firm, has agreed to acquire a majority stake in German pharmaceutical company Stada Arzneimittel, effectively halting the drugmaker’s previously explored initial public offering (IPO).
Market | 02/09/2025 | By Darshana | 527
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy